A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma

Clinical trial NCT00994175 · COMPLETED

Trial details

NCT number: NCT00994175
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Severe, Refractory Asthma Airway Inflammation Airflow Obstruction

Start date: 2009-09-23
Primary completion: 2016-06-24
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.